You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 9,006,387

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,006,387 protect, and when does it expire?

Patent 9,006,387 protects VIEKIRA XR, TECHNIVIE, and VIEKIRA PAK (COPACKAGED), and is included in three NDAs.

This patent has two hundred and seventy-two patent family members in forty-five countries.

Summary for Patent: 9,006,387

Title:	Anti-viral compounds
Abstract:	Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Inventor(s):	Wagner; Rolf (Antioch, IL), Pratt; John K. (Kenosha, IL), Liu; Dachun (Waukegan, IL), Tufano; Michael D. (Chicago, IL), DeGoey; David A. (Salem, WI), Kati; Warren M. (Gumee, IL), Hutchins; Charles W. (Green Oaks, IL), Donner; Pamela L. (Mundelein, IL), Randolph; John T. (Libertyville, IL), Motter; Christopher E. (Oak Creek, IL), Nelson; Lissa T. (Highland Park, IL), Patel; Sachin V. (Round Lake, IL), Matulenko; Mark A. (Libertyville, IL), Keddy; Ryan G. (Beach Park, IL), Jinkerson; Tammie K. (Pleasant Prairie, WI), Rockway; Todd W. (Grayslake, IL), Maring; Clarence J. (Palatine, IL), Hutchinson; Douglas K. (Antioch, IL), Flentge; Charles A. (Salem, WI), Betebenner; David A. (Libertyville, IL), Sarris; Kathy (Mundelein, IL), Woller; Kevin R. (Antioch, IL), Wagaw; Seble H. (Evanston, IL), Califano; Jean C. (Whitefish Bay, WI), Li; Wenke (Gumee, IL), Caspi; Daniel D. (Evanston, IL), Bellizzi; Mary E. (North Chicago, IL), Gao; Yi (Vernon Hills, IL), Krueger; Allan C. (Gumee, IL)
Assignee:	AbbVie Inc. (North Chicago, IL)
Application Number:	14/180,886
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,006,387
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 9,006,387

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	VIEKIRA XR	dasabuvir sodium; ombitasvir; paritaprevir; ritonavir	TABLET, EXTENDED RELEASE;ORAL	208624-001	Jul 22, 2016		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF HCV INFECTION USING OMBITASVIR	⤷ Try a Trial
Abbvie	TECHNIVIE	ombitasvir; paritaprevir; ritonavir	TABLET;ORAL	207931-001	Jul 24, 2015		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF HCV INFECTION USING OMBITASVIR	⤷ Try a Trial
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF HCV INFECTION USING OMBITASVIR	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,006,387

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	077060	⤷ Try a Trial
Argentina	083240	⤷ Try a Trial
Argentina	083398	⤷ Try a Trial
Argentina	092505	⤷ Try a Trial
Argentina	094816	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.